184 related articles for article (PubMed ID: 35376994)
21. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
[TBL] [Abstract][Full Text] [Related]
22. A Dual Role for P2X7 Receptor during Porphyromonas gingivalis Infection.
Ramos-Junior ES; Morandini AC; Almeida-da-Silva CL; Franco EJ; Potempa J; Nguyen KA; Oliveira AC; Zamboni DS; Ojcius DM; Scharfstein J; Coutinho-Silva R
J Dent Res; 2015 Sep; 94(9):1233-42. PubMed ID: 26152185
[TBL] [Abstract][Full Text] [Related]
23. Disruption of Purinergic Receptor P2X7 Signaling Increases Susceptibility to Cerebral Toxoplasmosis.
Moreira-Souza ACA; Rangel TP; Silva SRBD; Figliuolo VR; Savio LEB; Schmitz F; Takiya CM; Wyse ATS; Vommaro RC; Coutinho-Silva R
Am J Pathol; 2019 Apr; 189(4):730-738. PubMed ID: 30653952
[TBL] [Abstract][Full Text] [Related]
24. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
25. P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.
Savio LEB; Andrade MGJ; de Andrade Mello P; Santana PT; Moreira-Souza ACA; Kolling J; Longoni A; Feldbrügge L; Wu Y; Wyse ATS; Robson SC; Coutinho-Silva R
Mol Neurobiol; 2017 Oct; 54(8):6459-6470. PubMed ID: 27730511
[TBL] [Abstract][Full Text] [Related]
26. Purinergic signaling in infection and autoimmune disease.
Savio LEB; Coutinho-Silva R
Biomed J; 2016 Oct; 39(5):304-305. PubMed ID: 27884376
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.
Baudelet D; Lipka E; Millet R; Ghinet A
Curr Med Chem; 2015; 22(6):713-29. PubMed ID: 25515510
[TBL] [Abstract][Full Text] [Related]
28. Role of the purinergic signaling in epilepsy.
Cieślak M; Wojtczak A; Komoszyński M
Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186
[TBL] [Abstract][Full Text] [Related]
29. Cytokine storm in human monkeypox: A possible involvement of purinergic signaling.
da Silva GB; de Carvalho Braga G; Simões JLB; Kempka AP; Bagatini MD
Cytokine; 2024 May; 177():156560. PubMed ID: 38447385
[TBL] [Abstract][Full Text] [Related]
30. The anti-inflammatory effect of resistance training in hypertensive women: the role of purinergic signaling.
Lammers MD; Anéli NM; de Oliveira GG; de Oliveira Maciel SFV; Zanini D; Mânica A; de Resende E Silva DT; Bagatini MD; Sévigny J; De Sá CA; Manfredi LH; Cardoso AM
J Hypertens; 2020 Dec; 38(12):2490-2500. PubMed ID: 32694341
[TBL] [Abstract][Full Text] [Related]
31. P2X7 receptor and the NLRP3 inflammasome: Partners in crime.
Pelegrin P
Biochem Pharmacol; 2021 May; 187():114385. PubMed ID: 33359010
[TBL] [Abstract][Full Text] [Related]
32. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication.
De Nola R; Menga A; Castegna A; Loizzi V; Ranieri G; Cicinelli E; Cormio G
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096567
[TBL] [Abstract][Full Text] [Related]
33. IL-6 expression promoted by Poly(I:C) in cervical cancer cells regulates cytokine expression and recruitment of macrophages.
Liu X; Meng L; Chen L; Liang Y; Wang B; Shao Q; Wang H; Yang X
J Cell Mol Med; 2020 Feb; 24(3):2284-2293. PubMed ID: 31943744
[TBL] [Abstract][Full Text] [Related]
34. The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers.
Lupi LA; Cucielo MS; Silveira HS; Gaiotte LB; Cesário RC; Seiva FRF; de Almeida Chuffa LG
Life Sci; 2020 Apr; 247():117435. PubMed ID: 32081661
[TBL] [Abstract][Full Text] [Related]
35. ADA activity is decreased in lymphocytes from patients with advanced stage of lung cancer.
Zanini D; Manfredi LH; Pelinson LP; Pimentel VC; Cardoso AM; Carmo Araújo Gonçalves VD; Santos CBD; Gutierres JM; Morsch VM; Leal DBR; Schetinger MRC
Med Oncol; 2019 Aug; 36(9):78. PubMed ID: 31375946
[TBL] [Abstract][Full Text] [Related]
36. ATP binding cassette transporter ABC1 is required for the release of interleukin-1beta by P2X7-stimulated and lipopolysaccharide-primed mouse Schwann cells.
Marty V; Médina C; Combe C; Parnet P; Amédée T
Glia; 2005 Mar; 49(4):511-9. PubMed ID: 15578659
[TBL] [Abstract][Full Text] [Related]
37. The complex P2X7 receptor/inflammasome in perivascular fat tissue of heavy smokers.
Rossi C; Santini E; Chiarugi M; Salvati A; Comassi M; Vitolo E; Madec S; Solini A
Eur J Clin Invest; 2014; 44(3):295-302. PubMed ID: 24372548
[TBL] [Abstract][Full Text] [Related]
38. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
39. P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.
Zhao J; Wang H; Dai C; Wang H; Zhang H; Huang Y; Wang S; Gaskin F; Yang N; Fu SM
Arthritis Rheum; 2013 Dec; 65(12):3176-85. PubMed ID: 24022661
[TBL] [Abstract][Full Text] [Related]
40. ATP-induced IL-1β secretion is selectively impaired in microglia as compared to hematopoietic macrophages.
Burm SM; Zuiderwijk-Sick EA; Weert PM; Bajramovic JJ
Glia; 2016 Dec; 64(12):2231-2246. PubMed ID: 27641912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
